Neuralstem to Participate at Upcoming Investor Conferences

GERMANTOWN, Md., March 12, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that members of the management team will participate at the following upcoming investor conferences:

  • B. Riley FBR,